In summary, increased DFNA5 expression correlates with a poor prognosis in liver cancers and increased immune infiltration levels of CD8 + T cells, CD4 + T cells, macrophages, neutrophils and DCs of multiple cancers, especially in colon, liver and lung cancers. This evidence concerns the gene CD4 and lung carcinoma.